Global Factor VIII Deficiency Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Factor VIII Deficiency Treatment

• 1.1 Definition of Factor VIII Deficiency Treatment
• 1.2 Factor VIII Deficiency Treatment Segment by Type
  • 1.2.1 Global Factor VIII Deficiency Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Prophylaxis
  • 1.2.3 On-demand
  • 1.2.4 Inhibitor
• 1.3 Factor VIII Deficiency Treatment Segment by Applications
  • 1.3.1 Global Factor VIII Deficiency Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hemophilia A drugs
  • 1.3.3 Hemophilia A inhibitors treatment
  • 1.3.4 Von Willebrand disease treatment
• 1.4 Global Factor VIII Deficiency Treatment Overall Market
  • 1.4.1 Global Factor VIII Deficiency Treatment Revenue (2014-2025)
  • 1.4.2 Global Factor VIII Deficiency Treatment Production (2014-2025)
  • 1.4.3 North America Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Factor VIII Deficiency Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Factor VIII Deficiency Treatment
• 2.3 Manufacturing Process Analysis of Factor VIII Deficiency Treatment
• 2.4 Industry Chain Structure of Factor VIII Deficiency Treatment

3 Development and Manufacturing Plants Analysis of Factor VIII Deficiency Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Factor VIII Deficiency Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Factor VIII Deficiency Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Factor VIII Deficiency Treatment Production and Capacity Analysis
• 4.2 Factor VIII Deficiency Treatment Revenue Analysis
• 4.3 Factor VIII Deficiency Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Factor VIII Deficiency Treatment Regional Market Analysis

• 5.1 Factor VIII Deficiency Treatment Production by Regions
  • 5.1.1 Global Factor VIII Deficiency Treatment Production by Regions
  • 5.1.2 Global Factor VIII Deficiency Treatment Revenue by Regions
• 5.2 Factor VIII Deficiency Treatment Consumption by Regions
• 5.3 North America Factor VIII Deficiency Treatment Market Analysis
  • 5.3.1 North America Factor VIII Deficiency Treatment Production
  • 5.3.2 North America Factor VIII Deficiency Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Factor VIII Deficiency Treatment Import and Export
• 5.4 Europe Factor VIII Deficiency Treatment Market Analysis
  • 5.4.1 Europe Factor VIII Deficiency Treatment Production
  • 5.4.2 Europe Factor VIII Deficiency Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Factor VIII Deficiency Treatment Import and Export
• 5.5 China Factor VIII Deficiency Treatment Market Analysis
  • 5.5.1 China Factor VIII Deficiency Treatment Production
  • 5.5.2 China Factor VIII Deficiency Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Factor VIII Deficiency Treatment Import and Export
• 5.6 Japan Factor VIII Deficiency Treatment Market Analysis
  • 5.6.1 Japan Factor VIII Deficiency Treatment Production
  • 5.6.2 Japan Factor VIII Deficiency Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Factor VIII Deficiency Treatment Import and Export
• 5.7 Southeast Asia Factor VIII Deficiency Treatment Market Analysis
  • 5.7.1 Southeast Asia Factor VIII Deficiency Treatment Production
  • 5.7.2 Southeast Asia Factor VIII Deficiency Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Factor VIII Deficiency Treatment Import and Export
• 5.8 India Factor VIII Deficiency Treatment Market Analysis
  • 5.8.1 India Factor VIII Deficiency Treatment Production
  • 5.8.2 India Factor VIII Deficiency Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Factor VIII Deficiency Treatment Import and Export

6 Factor VIII Deficiency Treatment Segment Market Analysis (by Type)

• 6.1 Global Factor VIII Deficiency Treatment Production by Type
• 6.2 Global Factor VIII Deficiency Treatment Revenue by Type
• 6.3 Factor VIII Deficiency Treatment Price by Type

7 Factor VIII Deficiency Treatment Segment Market Analysis (by Application)

• 7.1 Global Factor VIII Deficiency Treatment Consumption by Application
• 7.2 Global Factor VIII Deficiency Treatment Consumption Market Share by Application (2014-2019)

8 Factor VIII Deficiency Treatment Major Manufacturers Analysis

• 8.1 Bayer HealthCare
  • 8.1.1 Bayer HealthCare Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.1.2 Bayer HealthCare Product Introduction, Application and Specification
  • 8.1.3 Bayer HealthCare Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 CSL
  • 8.2.1 CSL Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.2.2 CSL Product Introduction, Application and Specification
  • 8.2.3 CSL Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Grifols
  • 8.3.1 Grifols Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.3.2 Grifols Product Introduction, Application and Specification
  • 8.3.3 Grifols Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Novo Nordisk
  • 8.4.1 Novo Nordisk Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.4.2 Novo Nordisk Product Introduction, Application and Specification
  • 8.4.3 Novo Nordisk Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Pfizer
  • 8.5.1 Pfizer Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.5.2 Pfizer Product Introduction, Application and Specification
  • 8.5.3 Pfizer Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Shire
  • 8.6.1 Shire Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.6.2 Shire Product Introduction, Application and Specification
  • 8.6.3 Shire Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Alnylam Pharmaceuticals
  • 8.7.1 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.7.2 Alnylam Pharmaceuticals Product Introduction, Application and Specification
  • 8.7.3 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Amarna Therapeutics
  • 8.8.1 Amarna Therapeutics Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.8.2 Amarna Therapeutics Product Introduction, Application and Specification
  • 8.8.3 Amarna Therapeutics Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Biogen Idec
  • 8.9.1 Biogen Idec Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.9.2 Biogen Idec Product Introduction, Application and Specification
  • 8.9.3 Biogen Idec Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 BioMarin Pharmaceutical
  • 8.10.1 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Production Sites and Area Served
  • 8.10.2 BioMarin Pharmaceutical Product Introduction, Application and Specification
  • 8.10.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Catalyst Biosciences

9 Development Trend of Analysis of Factor VIII Deficiency Treatment Market

• 9.1 Global Factor VIII Deficiency Treatment Market Trend Analysis
  • 9.1.1 Global Factor VIII Deficiency Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Factor VIII Deficiency Treatment Regional Market Trend
  • 9.2.1 North America Factor VIII Deficiency Treatment Forecast 2019-2025
  • 9.2.2 Europe Factor VIII Deficiency Treatment Forecast 2019-2025
  • 9.2.3 China Factor VIII Deficiency Treatment Forecast 2019-2025
  • 9.2.4 Japan Factor VIII Deficiency Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Factor VIII Deficiency Treatment Forecast 2019-2025
  • 9.2.6 India Factor VIII Deficiency Treatment Forecast 2019-2025
• 9.3 Factor VIII Deficiency Treatment Market Trend (Product Type)
• 9.4 Factor VIII Deficiency Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Factor VIII Deficiency Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List